Nutrition and Exercise for Acute Lymphoblastic Leukemia
(NEOMA ALL Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how nutrition and exercise affect muscle and body fat in adults with Philadelphia Chromosome Negative B-ALL during hospital treatment. Participants will follow a nutrition plan and a physical exercise routine, with activity tracked by a Fitbit. It is ideal for those newly diagnosed with this condition and undergoing intensive chemotherapy. As an unphased trial, this study provides a unique opportunity to contribute to understanding lifestyle impacts on leukemia treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the research team.
Is there any evidence suggesting that this trial's interventions are likely to be safe?
Past studies have shown that exercise programs for patients with acute lymphoblastic leukemia (ALL) are safe. Research indicates these programs yield positive results without major safety issues. Patients with ALL who participated in exercise programs improved their physical activity and motor skills.
In contrast, nutrition programs lack clear information about their safety. More high-quality studies are needed to better understand their safety and effectiveness. While researchers are investigating nutrition programs, more evidence is required to confirm their safety and benefits.
Overall, both exercise and nutrition programs are generally considered safe, but stronger evidence supports the safety of exercise programs for patients with ALL.12345Why are researchers excited about this trial?
Researchers are excited about the Nutrition and Exercise interventions for Acute Lymphoblastic Leukemia (ALL) because they offer a holistic approach that complements traditional treatments like chemotherapy. Unlike conventional therapies that primarily focus on targeting cancer cells, these interventions aim to enhance the overall well-being and recovery of patients by promoting physical activity and optimal nutrition. This dual approach could potentially reduce treatment side effects, improve patients' quality of life, and support faster recovery, which are significant departures from the usual focus solely on eradicating cancer cells.
What evidence suggests that this trial's interventions could be effective for acute lymphoblastic leukemia?
Research shows that exercise is safe and beneficial for people with acute leukemia. Exercise can enhance fitness and reduce fatigue during and after treatment. Studies have found that staying active helps maintain mobility during chemotherapy.
Regarding nutrition, evidence suggests that eating the right foods can improve outcomes for people with acute lymphoblastic leukemia (ALL). Patients who follow personalized nutrition plans tend to live longer and experience fewer relapses. Good nutrition can also help manage weight and improve overall health during treatment.
In this trial, participants will receive both exercise and nutrition interventions while hospitalized for routine ALL treatment.12467Who Is on the Research Team?
Wendy Stock
Principal Investigator
University of Chicago
Are You a Good Fit for This Trial?
This trial is for adults with a type of blood cancer called Philadelphia Chromosome Negative B-ALL. They must be hospitalized for initial treatment and able to participate in both nutrition and exercise interventions. Specific details on who can or cannot join are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Induction Therapy
Participants undergo inpatient induction therapy with nutrition and exercise interventions
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Exercise Intervention
- Nutrition Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor